OMass Therapeutics, an Oxford spin-out built on native mass spectrometry, has raised £230 million (about $310 million) in a Series C that CEO ...

Who'll go next?

Henrik Pontoppidan, Director of S2U Design, reveals why ‘can’t be done’ are his favourite words in a Vietnamese furniture ...

A wonderful thing happened just as The Drum sat down to interview Ralph Rijks, chief marketing officer of Just Eat, shortly ...

Does black milk really give you glowing skin? A dermatologist explains the science behind the viral sesame drink and its ...

Aid groups warn of an imminent collapse of the health system as fighting continues to displace civilians amid the planting ...

Naza has incensed the Netanyahu administration. That means the documentary’s revelations have frightened it, says the ...

Oxford Instruments' Advanced Technologies division saw 125% order growth in H1, driven by datacom demand for AI ...

Prince Harry and wife Meghan make first joint appearance since UK return Prince Harry and his wife Meghan appeared together in public on Thursday for the first time since they made a surprise return ...

The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding the ...